Reshape Lifesciences Inc (NAS:RSLS)
$ 7.99 1.494 (23%) Market Cap: 4.05 Mil Enterprise Value: 2.40 Mil PE Ratio: 0 PB Ratio: 1.33 GF Score: 66/100

Q4 2019 Obalon Therapeutics Inc Earnings Call Transcript

Feb 27, 2020 / 01:30PM GMT
Operator

Good day, ladies and gentlemen, and welcome to the Obalon Therapeutics Fourth Quarter and Year-End 2019 Financial Results Conference Call. (Operator Instructions) As a reminder, this call is being recorded. I would now like to turn the conference over to Bill Plovanic, President and Chief Executive Officer for Obalon. Mr. Plovanic, you may begin, sir.

William John Plovanic
Obalon Therapeutics, Inc. - President, CEO, Secretary & Director

Thank you, operator. Good morning and welcome to Obalon Therapeutics Fourth Quarter and Year-End 2019 Financial Results Conference Call. With me on today's call are Bob Macdonald, Chief Retail Officer, who is responsible for driving future site expansion for the Obalon Center for Weight Loss retail treatment center model, a function that's similar to a role he played with Sono Bello, the largest aesthetic surgery chain in the United States. Also on today's call is Nooshin Hussainy, our Chief Financial Officer. This morning, the company issued a press release detailing our financial results for the 3 months and year ended

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot